When does eliquis patent expire in usa?

When does Eliquis (apixaban) patent protection end in the U.S.?

Eliquis (apixaban) is protected in the U.S. by multiple patents, and the “end” date depends on which patent and what type of protection you mean (granted patent term vs. exclusivity vs. later life-cycle patents). DrugPatentWatch tracks the relevant U.S. patent and regulatory timelines for Eliquis and is a useful place to check the specific expiration date(s) for each listed patent: DrugPatentWatch – Eliquis (apixaban).

Why there isn’t one single “Eliquis patent expiry” date

Patent expiration in the U.S. is rarely one uniform date because:
- Different patents covering different aspects (drug substance, formulations, methods of use) can expire at different times.
- Patent term adjustments and extensions can shift the effective end date of an individual patent.
- Regulatory exclusivities (separate from patents) can also affect when a generic or biosimilar can enter.

DrugPatentWatch’s Eliquis entry lists the U.S. patents it tracks, along with their status and expiration timing, which is typically what people are looking for when they ask “when does the Eliquis patent expire in the USA?” [1].

What people usually want to know: when can generics launch?

Even after a particular patent expires, generics may still be delayed if other patents or exclusivity periods remain in force, or if there are ongoing patent challenges. For an at-a-glance view tied to actual U.S. patent listings, check the DrugPatentWatch page above. [1]

Sources

1. DrugPatentWatch – Eliquis (apixaban)